Michael B. Zemel, Ph.D.

Michael B. Zemel, Ph.D.

Dr. Zemel comes to Kinexum from NuSirt Biopharma, where he serves as Chief Scientific Officer as well as company founder. At NuSirt, he developed and ran the discovery R&D program in metabolic health, leading to clinical stage asset development in obesity, diabetes and NASH.  He also led the NuSirt regulatory effort through Phase 2 in each of the company’s therapeutic areas and was responsible for clinical program development in each of these areas. Before starting NuSirt, he served as Professor of Medicine and of Nutrition at the University of Tennessee and prior to that was Professor of Endocrinology and Nutrition at Wayne State University with a concurrent position as Research Endocrinologist at the VA.  Dr. Zemel has authored or co-authored more than 200 clinical and basic peer-reviewed publications in numerous journals, including Proceedings of the National Academy of Sciences, New England Journal of Medicine, American Journal of Physiology, Endocrinology, Journal of Clinical Investigation, American Journal of Hypertension, PLoSOne, FASEB Journal, Metabolism, and Obesity.  He holds B.S., M.S. and Ph.D. degrees from the University of Wisconsin-Madison. 

Services Provided by Dr. Zemel include:

  • Translational drug product development
  • Regulatory and clinical development, including IND, regulatory communications and clinical protocols
  • Due diligence
  • Project management